Series C Funding Amount: What the Data Shows

The Number You Read Is Not the Number That Applies to You

I see this constantly - guides on Series C funding quoting a range like "$20M to $100M+" and calling it a day. A useless range is still a useless range, no matter how many sources repeat it.

Two completely different funding markets now operate under the same Series C label. One is the quiet majority. One is the one that makes headlines. Knowing which you are in changes everything about how you prepare, how much you target, and how investors will judge your round.

This piece breaks down what is happening with Series C funding amounts right now, using real data from Carta, real deal examples, and the patterns that emerge when you look at 157 actual Series C announcements side by side.

The Split: What Carta Sees vs. What Makes the News

Carta tracks tens of thousands of private funding rounds across the US startup ecosystem. Their data is the closest thing to ground truth on what closes.

According to Carta, the median Series C round size climbed from $15 million to $20.4 million in Q1 of the most recent recovery period, after the median had been shrinking for eight straight quarters. The average for the same period was $58.2 million, driven up by a small number of very large deals.

$20.4M median. $58.2M average. A handful of mega-rounds are pulling the average far above where most companies land.

Meanwhile, in public announcements on social media and in press coverage, the median Series C sits around $170 million. Deals under $100 million make up roughly 37% of announced rounds. Deals above $500 million make up about 21%.

Both numbers are accurate. They just describe different populations. Carta sees everything, including the quiet rounds at local SaaS companies and regional fintechs that never put out a press release. The announcement data reflects deals that founders and investors decided to shout about, which skews heavily toward larger, more dramatic closes.

If your company is Series C-stage and you are using the announcement data as your target, you are benchmarking against a very unrepresentative sample. If you are only looking at Carta's median, you are potentially under-targeting in a strong category.

The Exact Recovery Path (And Where the Market Sits Now)

The Series C market went through a sharp contraction between mid-2021 and end of 2023. Quarterly deal count fell by 61% over that stretch. Total capital raised at Series C went from $13.4 billion in Q2 2021 to just $2 billion in Q4 2023, an 85% decline according to Carta data.

Then came the recovery. Q1 of the recovery year saw a 130% quarter-over-quarter increase in capital raised at Series C, reaching $4.6 billion. The median valuation jumped 48% in a single quarter, which Carta noted was the largest quarterly percentage increase in Series C valuations of the decade so far.

For the full recovery year, Series C startups raised 41.8% more capital than the prior year. Deal count was up 34% year-over-year in Q4 of that same year.

The key takeaway: the trough was Q4 2023. If you are measuring your Series C targets against data from 2022 or 2023, you are using numbers from the bottom of a market cycle. The floor has risen significantly since then.

What a Series C Round Looks Like by Sector

Round sizes vary enormously by sector. The magnitude of the gap often surprises people.

Defense and aerospace deals have clustered in the $300 million to $470 million range in recent announcements, with companies like Skyryse closing a $300 million Series C and Hermeus raising $350 million. These companies have capital-intensive development cycles, which drives higher check requirements.

AI infrastructure is where the largest deals live. Nscale, an AI infrastructure company, secured $2 billion in Series C funding, which represented the largest Series C ever raised in Europe and set a $14.6 billion valuation. That is an extreme outlier, but it reflects the broader reality that AI infrastructure builds require capital at a scale traditional software did not.

AI robotics sits in a wide band. Robco raised $100 million at Series C while Skild AI raised $1.4 billion at a $14 billion valuation, building what they describe as a foundation model for robotics. Those two companies are technically in the same funding stage but occupy completely different financial universes.

For more traditional technology sectors, the range narrows considerably. Fintech deals have clustered between $36 million and $250 million. Biotech and longevity companies have generally landed between $100 million and $230 million. Legal AI company Steno raised a $49 million Series C to fund geographic expansion, which sits squarely in the traditional range for a category-emerging company.

What drives these differences? Three main factors. First, the capital intensity of the business model itself. Infrastructure and hardware require more upfront spend than pure software. Second, the competitive urgency of the market. AI is in a race where slowing down costs ground, which justifies larger raises. Third, the revenue trajectory at time of raise. A company at $50 million ARR growing 150% year-over-year commands a different conversation than one at $15 million ARR growing 40%.

The AI Bifurcation Inside Series C

AI companies now dominate the top of the Series C market. Analysis of the most-discussed Series C announcements finds that roughly 80% of the highest-engagement deals involve AI or machine learning companies.

The average Series C raise among AI companies in that sample is around $858 million, though that number is heavily distorted by a small number of extreme outliers. The median AI Series C is closer to $130 million. Non-AI sectors cluster in the $75 million to $170 million range when looking at announcement data.

This split matters for two reasons. First, if you are an AI company, your comps are legitimately different. Investors expect AI companies to raise more because compute costs, model training, and talent costs are genuinely higher. Second, if you are a non-AI company benchmarking against AI announcements, you are going to walk into investor meetings with expectations that do not match the category norms your investors will use.

US AI startups attracted $97 billion in venture funding in one recent year. AI secured nearly 50% of global venture funding in a recent tracking period, up from 34% the prior year. The mega-rounds at foundation model companies like OpenAI and Anthropic absorbed a large portion of that, but the pull-through effect has lifted Series C expectations across the AI sector as a whole.

For non-AI founders, the message is not discouraging. Your category is recovering and has its own reasonable comps. The mistake is using AI mega-round numbers to anchor your fundraising conversations.

Series C Valuations and What They Are Based On

The median primary Series C valuation on Carta was $195.7 million in the most recent strong recovery quarter, up 48% from the prior quarter's trough of $131.8 million.

At the top of the market, AI and deep tech companies are achieving valuations that look completely disconnected from those medians. Nscale's $2 billion Series C set a $14.6 billion valuation. Skild AI raised $1.4 billion at $14 billion. These are infrastructure and robotics plays where the addressable market is enormous and the competitive window is narrow.

For most Series C companies, valuation is built on a revenue multiple framework. SaaS companies at this stage typically see valuations in the 5x to 10x ARR range. Companies growing at 100%+ year-over-year can command higher multiples, sometimes 10x to 15x ARR. Companies in the 50% to 100% growth range generally land in the 7x to 10x window. Investors at Series C are no longer betting on potential. They are paying for demonstrated performance and the credibility of the forward plan.

One important benchmark: investors at this stage want to see $20 million to $50 million in ARR with a clear path to $100 million in revenue within 24 months. Some will consider $15 million ARR if annual growth is above 100% with strong unit economics. Below $10 million ARR is typically still Series B territory.

The way investors calculate your number is relatively straightforward. Take your current ARR. Apply a multiple based on your growth rate, retention, and market position. Subtract the ownership percentage they need to hit their fund return targets. That backs into the round size and valuation.

One practical data point on this: a SaaS company at $50 million ARR growing 100% year-over-year and trading at 10x ARR would have a $500 million pre-money valuation. A $75 million raise at that valuation means the investor gets about 13% post-money dilution, which aligns with the observed trend of declining dilution at Series C.

Dilution at Series C Is at a Multi-Year Low

One of the most founder-friendly trends right now is the decline in dilution at Series C. Carta data shows that median dilution on Series C rounds dropped from 13% in 2023 to around 10% in the most recent period. This means founders are giving up less equity per dollar raised at Series C than at any point in the past three years.

Compare that to seed stage, where dilution has moved only modestly, from around 21% to about 19.5% over the same period. The relative improvement is much larger at Series C.

Why is Series C dilution falling while round sizes are climbing? Two reasons. First, valuations have recovered faster than check sizes, so the same dollar of investment buys a smaller percentage of a more valuable company. Founders are also getting better terms because competition among investors for the best deals has pushed negotiating power their way.

The practical implication: a Series C round today, on average, dilutes founders by about 10%. If you can keep your raise under 15% of your post-money valuation, you are in line with current norms.

How Long You Wait Before Raising Series C

The median time between Series B and Series C rounds on Carta was 805 days, which works out to about 2.2 years. That number was up 14% year-over-year at the time of measurement, and 31% higher than it was two years before that.

Founders are waiting longer to raise Series C than they were during the 2020 to 2021 boom. The upside of the longer wait is that companies arrive at Series C with stronger metrics. The downside is that burn management between rounds has become more important.

Companies that raised big Series B rounds in the 2020 to 2021 window and then waited for the market to reset found themselves in a tricky position: strong on capital but facing down-round risk if they came to market too early. Several took bridge rounds instead of forcing a primary Series C at a distressed valuation. Carta data from the recovery period showed that bridge rounds at Series C had pushed higher valuations than primary rounds for six consecutive quarters before primary rounds regained their premium.

The current environment rewards patience and milestone achievement over speed. If you can push your ARR from $20 million to $35 million before raising, the valuation uplift typically outweighs the dilution from the delay.

What Oversubscription Looks Like at Series C

Oversubscribed Series C rounds are more common than the term implies. Looking at announced deals, a meaningful number of Series C rounds closed above their initial target. Skyryse, for example, set out to raise $150 million and closed at $300 million, more than doubling their target. Cognito Therapeutics was described as oversubscribed at $105 million.

The pattern behind oversubscription is consistent. Oversubscribed rounds tend to involve companies with strong social proof at the investor level. When Khosla Ventures, Lightspeed, or a16z signals early commitment, other investors pile in. Once a round is described as filling fast, the FOMO among investors accelerates the close.

The engagement data on oversubscribed deals confirms this dynamic. Founder-posted Series C announcements, where the founder describes the raise in their own words, average roughly 4x more social engagement than third-party news articles covering the same round. A Series C announcement signals to investors, future hires, and enterprise customers that the company has arrived.

If you are planning a Series C raise, your announcement strategy matters. A founder-led announcement with a clear narrative about what you are building and why this moment is right generates more downstream investor interest for future rounds than a wire service press release.

Who Invests at Series C and What They Want

At Series C, growth equity firms, hedge funds, private equity, and strategic corporate investors all enter the mix alongside traditional venture capital firms. This is the stage where institutional checks become standard.

Growth equity firms write checks of $75 million to $150 million for category leaders. Standard VC checks at this stage run $25 million to $100 million, with investors expecting to own 8% to 15% post-round. Check size varies significantly based on whether the investor is leading the round or following.

Series C investors care about sales efficiency metrics and competitive moat more than total addressable market. A pitch heavy on market size and light on unit economics signals a Series B mindset. A Series C deck should lead with retention data, cohort analysis, and a concrete plan to reach $100 million in revenue within 24 months.

Burn multiple is watched closely at this stage. Under 2x is the benchmark most investors cite. Net revenue retention above 110% signals the business has pricing power and customer value, which reduces the investor's risk on the growth assumptions. CAC to LTV ratios in the 1:3 to 1:5 range are expected minimums.

The most active lead investors in top-line Series C deals based on announcement frequency include Khosla Ventures, Lightspeed, Sequoia, and a16z. For non-AI sectors, growth equity specialists like Insight Partners, General Catalyst, and Coatue have been active leads across software and fintech Series C rounds.

The Funded Startup Signal I See Sellers Miss Every Week

One thing the Series C announcement data makes clear is that recently funded companies are not just fundraising milestones. They are buying signals.

When a company closes Series C, they have just received a mandate from institutional investors to grow. That mandate is explicit. Series C investors set growth targets tied to deployment of the capital. The CFO, CRO, and department heads are under active pressure to demonstrate progress within the next 12 to 18 months. Budgets are unallocated and the growth mandate is fresh the moment the round closes.

Companies at this stage commonly need performance marketing, customer success infrastructure, enterprise software, revenue operations tools, and security compliance services. Their team sizes have typically grown to between 100 and 500 employees, which creates demand for HR tools, training platforms, and operational automation.

The window matters. Outreach in the first 60 to 90 days after a Series C announcement tends to land better than outreach six months later, because early in the cycle the mandate is fresh and budgets are unallocated. One practitioner who built a system to identify companies under financial pressure described sending outreach specifically tied to recent funding signals, using the context of the raise as the first line of a cold email: acknowledging the growth mandate, then offering something directly relevant to achieving it. The specificity of that timing created responses that generic outreach never matched.

If you are in B2B sales and you are not actively monitoring Series C announcements in your target vertical, you are walking past the warmest outreach window available. Tools that let you filter by funding stage, industry, and company size make it possible to catch those windows at scale rather than relying on news alerts. Try ScraperCity free to search and filter recently funded companies by title, industry, location, and company size, so you can reach the right decision-maker at exactly the right moment.

What a Series C Pitch Must Show That Series B Did Not

The mental model shift between Series B and Series C is significant. At Series B, you are proving that the business can scale. Series C is about proving you are the dominant player in a defensible market with a clear path to a major exit.

Series B investors are willing to bet on a strong growth trajectory. Series C investors are investing in proven businesses with clear paths to IPO or acquisition. The due diligence is deeper, the financial scrutiny is more intense, and the governance expectations are higher.

In terms of the pitch itself, Series C decks that perform best spend more time on proof of market leadership than on market opportunity size. Investors at this stage assume the market is large enough. What they want to see is evidence that your company will be the winner, not just a participant.

The specific data points that matter most at Series C include net revenue retention by cohort, customer concentration analysis, payback period trends over the last four to six quarters, and a revenue model that shows how the capital will compound. Investors typically want to see 24 to 36 months of financials in the data room, along with the last four to six board decks, so they can trace the decision history of the management team.

One pattern that emerges from high-engagement Series C announcements is the emphasis on mission and timing. The best-performing founder announcements describe what is changing in their sector and why this particular moment required capital at scale. It answers the investor question that sits underneath every Series C term sheet: why now?

The Quiet Majority vs. The Noisy Top

The conversation about Series C funding amounts tends to center on the deals that get covered. But the distribution is much wider than the coverage suggests.

Looking at deal data segmented by size: roughly 37% of tracked Series C deals are under $100 million. About 16% fall between $100 million and $200 million. Another 26% land between $200 million and $500 million. And 21% exceed $500 million.

The sub-$100 million deals almost never make major tech press. They close without a press release. Vertical SaaS for specific industries. Regional fintech. Compliance tools that nobody outside the industry follows. Healthcare infrastructure moving slower than anyone wants.

These companies face a specific challenge: their round size benchmarks are being set by announcement data that does not include them. When a founder in vertical SaaS reads that the average Series C is $170 million, and their own deal is $35 million, they assume they are undersized. They may not be. They may just be in the quiet majority, which has its own perfectly healthy set of norms.

Carta's median round size, in the $20 million to $23 million range during the recovery period, reflects this quiet majority. These are companies raising appropriate capital for their stage, sector, and growth trajectory, not companies trying to match the AI infrastructure announcements that dominate the news feed.

The practical implication for founders in this segment: use sector-specific comps, not headline comps, when setting your round size target. A $30 million Series C for a vertical SaaS company at $12 million ARR with 90% net revenue retention is a strong round in that market. Compare it to the Nscale deal and it looks small. Compare it to actual deals in comparable categories and it looks exactly right.

How to Think About Round Size When You Are Raising

There is no formula that works universally. But there is a framework that most Series C investors recognize and respond to.

Start with your 24-month plan. What does the business need to achieve in 24 months to justify a Series D or a strong exit? Work backward from that to the specific use of capital: headcount, product investment, market expansion, acquisition. The sum of those line items, with a reasonable buffer, is your raise target.

Then pressure-test it against two benchmarks. First, the dilution check. If hitting your target requires you to give up more than 20% post-money at your current valuation, either your valuation is too low or your raise is too high. At current market norms, Series C dilution around 10% is what the data supports. Second, the runway check. Series C capital should ideally carry you 18 to 24 months or longer. If you are burning $3 million per month and you are raising $30 million, you have 10 months of runway on the raise alone. That is tight for a Series C and investors will notice.

The mistake that shows up most often in failed Series C processes is a mismatch between the raise target and the use of funds. Investors ask, specifically, what you will do with the money. A founder who says "we will invest in growth" is describing an intention. A founder who says "we will add 40 enterprise sales reps in three priority markets to capture the 180 target accounts our data shows are ready to buy, and we expect $18 million in incremental ARR from that motion in 24 months" is describing a plan. The second founder raises faster and on better terms.

The specific number matters less than the credibility of the logic behind it. Series C investors have seen enough rounds to know when a raise target was reverse-engineered from "what I want" versus derived from "what the business requires." The ones who raise best are the ones who have done the math, can defend every line item, and can explain what happens to the business if they miss on any assumption.

What Happens After Series C

Series C is a commitment. The capital comes with explicit expectations, and the clock starts running the moment the round closes.

Companies that use Series C well typically pursue one or more of four paths: market expansion into new geographies, product diversification into adjacent solutions, acquisitions that consolidate market share or add capabilities, or direct IPO preparation. The specific path depends on the company's competitive position and the exit timing preferences of the investor base.

IPO preparation has become more prominent in the Series C conversation in recent cycles. Several major companies have either extended their Series C timeline or raised Series C specifically to get the business IPO-ready. This includes building out the finance, compliance, and reporting infrastructure that public company status requires.

Companies that do not use the capital well tend to fall into three traps. Over-expansion, meaning entering too many markets at once without enough depth in any of them. Runaway burn, which means hiring aggressively on the assumption of continued growth without maintaining efficiency discipline. And timing mismatches, where the company raises Series C too early before the metrics are truly Series C-grade and then struggles to show the expected trajectory once the round closes.

The best proxy for Series C success is what happens to net revenue retention in the 12 months after the round. Companies that maintain NRR above 110% while deploying capital efficiently tend to have strong Series D outcomes or successful exit events. Companies whose NRR falls below 100% after a large raise typically face significant challenges at the next stage.

The Full Picture: Series C Funding Amounts in One View

Here is a consolidated view of what the data shows across sources and deal types.

At the broad market level, looking at all Series C deals on Carta, the median round size is in the $20 million to $23 million range, with an average of $58 million. The median valuation at this stage has recovered to around $195 million from a trough of $131 million. Dilution has fallen to around 10% at Series C, the lowest in three years. Time between Series B and Series C is about 2.2 years.

At the announced deal level, the median round in public announcements sits around $170 million, with 21% of deals exceeding $500 million. AI companies dominate the high end, with the average AI Series C around $130 million in the median and much higher in the mean due to outliers like Nscale's $2 billion raise and Skild AI's $1.4 billion.

By sector, defense and aerospace cluster at $300 million to $470 million. AI infrastructure can reach $2 billion or more. Traditional SaaS and fintech Series C rounds generally fall between $25 million and $150 million. Biotech and longevity land between $100 million and $230 million.

The bifurcation between quiet rounds and announced rounds is a structural feature of the market. Some companies raise appropriate capital for their category. Others are in high-intensity competitive races where the size of the round is itself a competitive signal.

Understanding which market you are in is the most important thing you can do before you start talking to investors.